These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1686099)

  • 1. Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1991 Jul; 39(3):575-9. PubMed ID: 1686099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
    Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
    Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of different 4-aminopyridine and morphine combinations on the intensity of morphine abstinence.
    Koyuncuoğlu H; Nurten A; Enginar N; Ozerman B; Kara I
    Pharmacol Res; 2001 Mar; 43(3):245-50. PubMed ID: 11401416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine physical dependence intensification by hypoglycemia: NMDA receptor involvement.
    Koyuncuoğlu H; Hatipoğlu I; Sarica O
    Pharmacol Biochem Behav; 1994 Jul; 48(3):571-4. PubMed ID: 7938107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats.
    Koyuncuoğlu H; Güngör M; Sağduyu H; Aricioğlu F
    Pharmacol Biochem Behav; 1990 Apr; 35(4):829-32. PubMed ID: 2345761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neonatal monosodium glutamate and aging on morphine dependence development.
    Koyuncuoğlu H; Aricioğlu F; Dizdar Y
    Pharmacol Biochem Behav; 1992 Oct; 43(2):341-5. PubMed ID: 1438475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tizanidine on morphine physical dependence: attenuation and intensification.
    Koyuncuŏglu H; Ariciŏglu F; Uresin Y; Dizdar Y; Esin Y
    Pharmacol Biochem Behav; 1992 Aug; 42(4):693-8. PubMed ID: 1355295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats.
    Sayin U; Atasoy S; Uzbay IT; Aricioğlu-Kartal F; Koyuncuoğlu H
    Pharmacol Res; 1998 Jul; 38(1):45-51. PubMed ID: 9697154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence.
    Fundytus ME; Coderre TJ
    Br J Pharmacol; 1994 Dec; 113(4):1215-20. PubMed ID: 7889275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral alterations produced by chronic naloxone injections.
    Malin DH; Layng MP; Swank P; Baker MJ; Hood JL
    Pharmacol Biochem Behav; 1982 Sep; 17(3):389-92. PubMed ID: 6890681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of glutamate receptor agonists in morphine-dependent rats.
    Dravolina OA; Medvedev IO; Bespalov AY
    Behav Pharmacol; 1999 Jul; 10(4):359-66. PubMed ID: 10780804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butorphanol precipitates abstinence in morphine dependent rats.
    Horan P; Ho IK
    Eur J Pharmacol; 1989 Nov; 170(3):265-8. PubMed ID: 2620698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.